Marc Semigran

Companies

• Edgewise Therapeutics, Inc.Chief Development Officer Dec 22, 2022 to Dec 27, 2024¹
• Renovacor, Inc.Chief Medical Officer Sep 7, 2021 to Dec 5, 2022²
• PROKIDNEY CORP.Board member Jun 29, 2021 to Jun 29, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEdgewise Therapeutics, Inc. EWTX6,716 shares⁴$249.8K at $37.19Dec 24, 2024
• RRenovacor, Inc.0 shares⁵Dec 1, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 24, 2024Sold 1,729 shares at $30.08 of Edgewise Therapeutics, Inc.⁴
• Dec 24, 2024Sold 27,980 shares at $29.66 of Edgewise Therapeutics, Inc.⁴
• Dec 24, 2024Exercised options 29,709 shares at $8.94 of Edgewise Therapeutics, Inc.⁴
• Dec 1, 2022Returned to company 35,226 shares of Renovacor, Inc.⁵
• Dec 1, 2022Granted 35,226 shares of Renovacor, Inc.⁵
• Dec 1, 2022Returned to company 17,425 shares of Renovacor, Inc.⁵
• Jan 24, 2022Granted 17,425 shares of Renovacor, Inc.⁶